The Great Debate: When to Treat Hepatitis C Virus in HIV Co-infected Patients, presented by Brad Hare, MD and Annie Luetkemeyer, MD
In this webinar, Dr. Hare and Dr. Luetkemeyer provide a brief update of the newest HCV treatment options and disucss 3 cases of co-infected patients. They review each case and discuss the appropriate considerations when determining who is appropriate for HCV treatment and why.
- Describe treatment outcomes using currently available HCV treatment regimens
- Identify and balance pros and cons of HCV treatment with currently available and anticipated regimens
- Identify appropriate treatment for HIV/HCV co-infected patients
Brad Hare, MD is an Associate Professor of Medicine at UCSF and Medical Director of the HIV/AIDS Clinic at San Francisco General Hospital. He has been treating HIV and HCV for over 12 years and helped to found the Co-infection Clinic at San Francisco General Hospital. He has published numerous articles on both HIV and HCV treatment.
Annie Luetkemeyer, MD is an Assistant Professor of Medicine at UCSF and Attending Physician at the HIV/AIDS Clinic at San Francisco General Hospital. She is active nationally in designing and conducting clinical trials of hepatitis C treatments in both mono-infected and co-infected patients and has published numerous articles in the fields of HIV and HCV. She has an active clinical practice of HIV and HIV/HCV co-infected patients at San Francisco General Hospital and is an attending physician in the Co-infection Clinic.
Downloads and Links
When to Treat HCV in our HIV Co-infected Patients: 2013 Perspective (1432 KB):
Adobe Connect Recording: